This compound is a synthetic nucleoside analog intermediate featuring a benzamide-substituted pyrimidine base linked to a modified ribose sugar. It is primarily used in the pharmaceutical manufacturing of nucleotide-based therapeutics.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 340162-93-8
N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
nucleoside phosphoramidite building block intermediate
Adenosine, N-benzoyl-2'-O-(2-methoxyethyl)-
Pharmaceutical intermediate for nucleoside analogs
6-fluoro-7H-purin-2-amine
Pharmaceutical intermediate for nucleoside analogs
5-Methylcyclocytidine hydrochlorine
Pharmaceutical intermediate for nucleoside analogs
[(2S,3S,4S,5S)-3,4-diacetyloxy-5-(4,6-dichloroimidazo[4,5-c]pyridin-1-yl)oxolan-2-yl]methyl acetate
Pharmaceutical intermediate for nucleoside analogs
5-(4-chlorophenyl)-2-furaldehyde
pharmaceutical intermediate
3,4-Difluorobenzaldehyde
Pharmaceutical intermediate
2,5-Oxazolidinedione, 4-[(4-hydroxyphenyl)methyl]-, (4S)-
Pharmaceutical intermediate
N-[1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
LGGHYGUGIGYDFX-YKTARERQSA-N
CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)OCCOC
—